Susan Fisher, PhD, MS, named Associate Cancer Center Director for Community Outreach and Health Disparities at Fox Chase Cancer Center

PHILADELPHIA (May 21, 2019) – Susan Fisher, PhD, MS, has been named Associate Cancer Center Director for Community Outreach and Health Disparities at Fox Chase Cancer Center. She will supervise the Office of Community Outreach and serve in an advisory role in cancer health disparities on the campus.

In addition to accepting this position, Dr. Fisher will retain her roles as Chair of the Department of Clinical Sciences and Professor of Clinical Sciences at the Lewis Katz School of Medicine at Temple University. Dr. Fisher’s specific research interests include cancer, public health, clinical trial design, epidemiologic studies, and lymphoma epidemiology.

“Her experience and expertise in these areas together with her leadership insights will be an invaluable resource to our faculty and staff,” said Richard I. Fisher, MD, President & CEO of Fox Chase Cancer Center. “I look forward to seeing how her work at Fox Chase will further inform our clinical, research, and outreach programs.”

An accomplished epidemiologist and academic leader, Dr. Fisher has promoted the acceleration of clinical research through innovation and collaboration across scientific disciplines. Her work at Temple demonstrates her leadership in important areas, such as biostatistics, bioinformatics, clinical and quantitative epidemiology, urban health outcomes, and education in clinical sciences. Of particular note is the success of Temple Health: Block-by-Block (THB3), which focuses on engaging local residents to better understand their health concerns and to empower them in partnering with researchers to advance community research, health services, and patient outcomes.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427